Mental Health

The study evaluated whether conditions such as depression in adolescence are associated with a higher risk of cardiovascular disease in adulthood.

How would you respond to these patients?

This is the first study to systematically investigate whether individual blood pressure medications might influence the risk of developing depression, according to the authors.

Over the course of the COVID-19 pandemic, Google searches for anxiety have climbed 17%.

Abdominal weight gain during the postmenopausal period is associated with the use of antidepressants, beta-blockers, and insulin during the menopause transition.

Patients with peripheral artery disease and depressive symptoms experience worse recovery than patients without depressive symptoms.

Top news of the week from Pharmacy Times®.

New research indicates a need to understand the mental health impacts of the coronavirus disease 2019 pandemic.

Helath care workers report higher levels of stress, anxiety, and fatigue, as well as reduced feelings of control over their lives, as a result of COVID-19.

Mental health first aid training is being incorporated into pharmacy curricula to address suicide prevention and other crises.

Study shows an increase in anxiety and depression among college students since the start of the coronavirus disease 2019 pandemic.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Esketamine shows promise for adults suffering from treatment-resistant depression.

Along with the duty to care for patients with COVID-19 is the psychological burden that develops in frontline care professionals, such as pharmacists.

Published in the American Journal of Respiratory and Critical Care Medicine, the latest ATS practice guideline maintains the first principle of clinical practice, that “all patients who use tobacco should receive treatment for their dependence, and not simply be encouraged to stop.”

At the 2020 Virtual Conference on Pediatric Health Care, Kimberly Erlich presented an update on current understandings of pharmacogenomic testing and its use as a tool in the treatment of behavioral health issues in a pediatric population.

The current pandemic has been trauma-inducing for many and telehealth needs to rise to the occasion.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Insufficient sleep can have negative emotional effects in young children.

Probiotic therapy either with prebiotics or by itself may ease depression, according to a review of the data recently published in BMJ Nutrition Prevention & Health.

In addition to finding that depression affects up to 70% of women transitioning into menopause, investigators have also identified the greatest risk factors.

Caplyta is an atypical antipsychotic and is thought to exert its effect through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.

At the 2020 Virtual Conference on Pediatric Health Care, Dawn Garzon Maaks, discussed important elements in the diagnosis and treatment of tics in children with ADHD.

Even if they don’t contract the disease, patients living with obesity have found the pandemic to be harmful to their emotional and physical health.

Although many children have normal fears for their age that are not a sign of anxiety, fears become anxiety when they are impairing a child's life.

Kimberly Erlich, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project and Consulting Associate Faculty, Duke University School of Nursing, discusses considerations for pharmacogenomic testing in the pediatric population for behavioral health treatment.

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.

Pharmacy Times® interviewed Susan Van Cleve, Clinical Professor and Primary Care Pediatric Nurse Practitioner program director, University of Iowa College of Nursing, on identifying and treating anxiety in children and teens who present comorbidities.

In the United States, 3.5 million people have been diagnosed with schizophrenia and it is a leading cause of disability.

individuals with four or more depressive symptoms had a 20% increase in cardiovascular events and death.